ANT BIO PTE. LTD. Exclusive Promotion
15 Apr 2026
by AntBio
Official Article: ANT BIO PTE. LTD. Exclusive Promotion
Article Type: Literature Analysis + Knowledge Highlights
Topic: HSPA8 (UniProt: P10636) – Molecular Chaperone, Disease Mechanisms, and Targeted Therapy
Published by: ANT BIO PTE. LTD.
1. Literature Information
This literature review systematically summarizes the molecular characteristics, functional mechanisms, and translational applications of HSPA8 (P10636), a member of the heat‑shock protein 70 (HSP70) family. It covers the roles of HSPA8 in protein homeostasis, neurodegenerative diseases, cancer progression, infectious diseases, and the development of targeted therapeutic strategies.
2. Research Background
Protein homeostasis is essential for cell survival and function. As a highly conserved molecular chaperone, HSPA8 maintains intracellular protein quality control, assists protein folding, and prevents abnormal aggregation. Dysregulation of HSPA8 is closely associated with the pathogenesis of neurodegenerative disorders, malignant tumors, and viral/bacterial infections. Targeting HSPA8 has become a promising strategy for disease intervention.
3. Research Methodology
- Bioinformatics analysis of molecular structure and functional domains
- In vitro protein refolding and chaperone activity assays
- Cell‑based models for tumor, neurodegeneration, and infection
- In vivo animal models for therapeutic evaluation
- Drug screening and gene‑editing strategies targeting HSPA8
4. Research Findings
- HSPA8 contains an N‑terminal ATPase domain and a C‑terminal substrate‑binding domain, enabling ATP‑dependent chaperone activity.
- HSPA8 is essential for protein folding, intracellular trafficking, and autophagy‑dependent protein degradation.
- In neurodegenerative diseases, HSPA8 exerts dual effects: promoting the clearance of misfolded proteins and potentially regulating pathological protein propagation.
- In cancer, overexpression of HSPA8 enhances tumor cell survival, migration, and chemotherapy resistance.
- HSPA8 is involved in the life cycles of multiple viruses and the immune evasion of intracellular bacteria.
- Targeted inhibition or modulation of HSPA8 represents a novel therapeutic approach for multiple diseases.
5. Product Empowerment (ANT BIO PTE. LTD.)
ANT BIO PTE. LTD. provides a full line of high‑quality reagents to support research on HSPA8 and related fields:
- Antibodies: Highly specific anti‑HSPA8 antibodies for WB, IHC, IF, and IP
- Proteins: Recombinant HSPA8 protein for functional studies
- Kits: Chaperone activity assay kits and protein homeostasis detection kits
- General reagents: Buffers, secondary antibodies, and supporting reagents
These products ensure stable, reliable, and reproducible experimental results for basic research and drug discovery.
6. Brand Mission
ANT BIO PTE. LTD. is a professional supplier of life science reagents. Our main products include antibodies, proteins, assay kits, and general laboratory reagents. We have three specialized sub‑brands:
- Absin: General reagents and assay kits
- Starter: High‑quality antibodies
- UA: Premium recombinant proteins
We are committed to providing researchers with stable, reliable, and high‑performance tools to accelerate scientific discovery and translational medicine.
7. Related Product List
- Anti‑HSPA8 (P10636) Rabbit Polyclonal Antibody
- Anti‑HSPA8 Mouse Monoclonal Antibody
- Recombinant Human HSPA8 Protein
- Protein Chaperone Activity Assay Kit
- General Buffer Kit for Protein Research
- HRP‑conjugated Secondary Antibody
- Western Blot Detection Kit
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high‑quality, reliable reagents and comprehensive solutions. Our specialized sub‑brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer‑centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
